Advertisement
Screener

Shattuck Labs, Inc. (STTK) ROA

Shattuck Labs, Inc. (STTK) ROA

  • 2026-06-30: ROA -23.82%.
  • 2026-03-31: ROA -48.84%.
  • 2025-12-31: ROA -53.62%.
  • 2025-09-30: ROA -54.71%.

Complete source-backed roa history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-23.82%
2026-03-31-48.84%
2025-12-31-53.62%
2025-09-30-54.71%
2025-06-30-95.56%
2025-03-31-91.50%
2024-12-31-82.82%
2024-09-30-66.61%
2024-06-30-66.31%
2024-03-31-58.14%
2023-12-31-54.71%
2023-09-30-72.84%
2023-06-30-59.33%
2023-03-31-55.24%
2022-12-31-49.65%
2022-09-30-30.81%
2022-06-30-24.45%
2022-03-31-21.33%
2021-12-31-15.06%
2021-09-30-20.88%
2021-06-30-18.30%
2021-03-31-12.43%
2020-12-31-10.49%
2020-09-30-22.06%
2019-12-31-53.33%

Annual ROA

DateROA
2025-12-31-53.62%
2024-12-31-82.82%
2023-12-31-54.71%
2022-12-31-49.65%
2021-12-31-15.06%
2020-12-31-10.49%
2019-12-31-53.33%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neurogene Inc. (NGNE)$0.625B-4.46
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
CorMedix Inc. (CRMD)United States$0.605B3.25
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
Climb Bio, Inc. (CLYM)United States$0.683B-13.03